Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.
about
AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011.Aromatase inhibitors-induced bone loss in early breast cancer.Guidelines for Osteoprotection in Breast Cancer Patients on an Aromatase Inhibitor.Femur fracture classification in women with a history of breast cancer.Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancerManagement of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGOptimal management of cancer treatment-induced bone loss: considerations for elderly patients.A prospective model of care for breast cancer rehabilitation: bone health and arthralgias.Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES).Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.
P2860
Q30318240-654B59CC-7587-4889-AC9E-2FA56C3CD5A1Q33752867-9DA002BB-47C0-4801-9B1A-D364E1197C0FQ35095538-D7264035-54CF-45E8-B3A0-68D01ABB00C3Q36492212-717CD5EC-F743-471A-9020-28D5851D66A7Q37356084-C65AE92C-8CC8-4FD6-A86E-680A2DAAED56Q37742180-C5DDA832-3151-47E1-9A2F-B1B4EAF16BEDQ37952851-C19D3782-0B67-4827-8F03-1FD0C39BCFE5Q38001377-A3F6433E-1A3A-441E-8962-B7DEF86120F5Q40519548-DA59824D-21EF-4F87-BD13-281607AE1F03Q51393764-7E390BD7-72EC-4FC7-95AA-92A4A236D16EQ53136867-FA2360BE-0B5F-4255-BAD6-E3F14BAA01F2
P2860
Assessment of fracture risk in women with breast cancer using current vs emerging guidelines.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Assessment of fracture risk in ...... urrent vs emerging guidelines.
@ast
Assessment of fracture risk in ...... urrent vs emerging guidelines.
@en
type
label
Assessment of fracture risk in ...... urrent vs emerging guidelines.
@ast
Assessment of fracture risk in ...... urrent vs emerging guidelines.
@en
prefLabel
Assessment of fracture risk in ...... urrent vs emerging guidelines.
@ast
Assessment of fracture risk in ...... urrent vs emerging guidelines.
@en
P2093
P2860
P356
P1476
Assessment of fracture risk in ...... urrent vs emerging guidelines.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605548
P407
P577
2010-01-19T00:00:00Z
P5875
P6179
1050094312